Historical biases in research, diagnosis, and treatment of disease have long resulted in limited or ineffective medical care for women. The National Institutes of Health Revitalization Act of 1993 requires the inclusion of women and minorities in NIH-funded clinical trials and has increased awareness of disparate health outcomes between men and women, although serious inequities continue to this day. In this Next in Science program, we will explore innovative research and policy that address critical needs and improve health outcomes for women through the latest developments in public health, mental health, diagnosis and treatment, and drug discovery.

The Next in Science series provides an opportunity for early-career scientists whose creative, cross-disciplinary, and cutting-edge research is thematically linked to introduce their work to non-specialists, fellow scientists, and one another.

Harvard Radcliffe Institute gratefully acknowledges the Melanie Mason and David W. Niemiec Fund for Science, which is supporting this event.

Speakers

• Victoria Brown, biology/drug discovery consultant, Versant Ventures
• Tara Castellano, assistant professor, clinical, Louisiana State University Health Sciences Center Department of Obstetrics and Gynecology
• Laramie E. Duncan, assistant professor, Department of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translation Neurosciences Incubator Division), Stanford University
• Étienne Holder, postdoctoral associate, Boston University Chobanian & Avedisian School of Medicine and Slone Epidemiology Center

Moderator

• Immaculata De Vivo, Melanie Mason Niemiec ’71 Faculty Codirector of the Sciences, Harvard Radcliffe Institute; professor of medicine, Harvard Medical School; professor of epidemiology, Harvard T.H. Chan School of Public Health